ENACT

Launch of the ENACT Project

We are excited to announce the official launch of the ENACT project, a groundbreaking initiative funded by the European Commission under the Horizon program. The project aims to advance health technologies and biotechnological innovations that will significantly improve healthcare delivery across Europe.

The ENACT project is coordinated by the Alliance for IoT and Edge Computing Innovation (AIOTI) and involves a diverse consortium of partners, including leading institutions from various European countries. The Health and Life Sciences Cluster (HLSC) is proud to be a key beneficiary in this collaborative effort, contributing our expertise in biotechnological research and health innovation.

Key Objectives of ENACT:

Innovative Solutions: Develop and implement cutting-edge biotechnological applications that enhance patient care and improve health outcomes.

Stakeholder Engagement: Foster collaboration between healthcare providers, researchers, and industry stakeholders to ensure that innovations meet real-world needs.

Data-Driven Insights: Utilize advanced data analytics to derive insights that inform healthcare practices and policies.

Project Timeline:

The ENACT project is set to unfold over the next several years, with significant milestones planned for stakeholder engagement, research implementation, and dissemination of findings.

We invite you to follow our journey as we work towards transforming healthcare through innovation. 

List of Participants in the ENACT Project

Coordinator:

ALLIANCE FOR IOT AND EDGE COMPUTING INNOVATION IVZW (AIOTI)

Location: Brussels, Belgium

Other Beneficiaries:

AICRUM IT SL (AIC)

Location: Murcia, Spain

BRIDG OU (BRD)

Location: Tallinn, Estonia

EREVNITIKO PANEPISTIMIAKO INSTITOUTO SYSTIMATON EPIKOINONION KAI YPOLOGISTON (ICCS)

Location: Athens, Greece

FONDAZIONE LINKS - LEADING INNOVATION & KNOWLEDGE FOR SOCIETY (LINKS)

Location: Turin, Italy

FUNDACION EMPRESA UNIVERSIDAD GALLEGA (FEUGA)

Location: Santiago de Compostela, Spain

FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL INFANTIL UNIVERSITARIO NINO JESUS (FHUNJ)

Location: Madrid, Spain

BIOTEHNOLOGICHEN I ZDRAVEN KLASTER (HLSC)

Location: Sofia, Bulgaria

INSTITOUTO ANAPTIXIS EPICHEIRIMATIKOTITAS ASTIKI ETAIREIA (iED)

Location: Larissa, Greece

LAUREA-AMMATTIKORKEAKOULU OY (LAUREA)

Location: Vantaa, Finland

ORTHOKEY ITALIA SRL (OKEY)

Location: Carrara, Italy

RESEARCH FOR SCIENCE, ART AND TECHNOLOGY (RFSAT) LIMITED (RFSAT)

Location: Dublin, Ireland

ASSOTSIATSIA ZA RAZVITIE NA SOFIA (SDA)

Location: Sofia, Bulgaria

SOFTWARE IMAGINATION & VISION SRL (SIMAVI)

Location: Bucharest, Romania

SOUTH EAST TECHNOLOGICAL UNIVERSITY (SETU)

Location: Waterford, Ireland

TECHNISCHE UNIVERSITEIT DELFT (TUD)

Location: Delft, Netherlands

UNIVERSITAS NEBRISSENSIS SA (UNNE)

Location: Hoyo de Manzanares, Spain

FUNDACION CENTRO DE TECNOLOGIAS DE INTERACCION VISUAL Y COMUNICACIONES VICOMTECH (VICOM)

Location: San Sebastian, Spain

VIRTECH OOD (VIRT)

Location: Sofia, Bulgaria

VRIJE UNIVERSITEIT BRUSSEL (VUB)

Location: Brussels, Belgium

UDIT ESTUDIOS SUPERIORES INTERNACIONALES S.L. (UDIT)

Location: Madrid, Spain

This diverse consortium includes organizations from across Europe specializing in various fields such as biotechnology, ICT innovation, research institutions, and healthcare. 

The core aim of the ENACT project is to advance health technologies and biotechnological innovations that enhance healthcare delivery and improve health outcomes across Europe. Specifically, the project focuses on:

Development of Innovative Solutions: ENACT aims to create and implement cutting-edge biotechnological applications tailored to address current health challenges.

Collaboration and Stakeholder Engagement: The project emphasizes fostering collaboration among various stakeholders, including healthcare providers, researchers, and industry partners, to ensure that the developed solutions meet real-world needs.

Data-Driven Insights: Utilizing advanced data analytics to derive actionable insights that inform healthcare practices and policies is a critical component of the project.

Ethical Compliance: ENACT is committed to adhering to high ethical standards in all research activities, ensuring that innovations are developed responsibly.

Dissemination of Findings: The project aims to effectively communicate its results and innovations to stakeholders and the public, promoting awareness and application of its findings in the healthcare sector.

Overall, ENACT seeks to contribute significantly to the improvement of health systems in Europe through innovative biotechnological advancements and collaborative efforts among diverse partners.


Together, we can make a difference in the future of health and biotechnology!

For inquiries or further details, please contact us at biocluster@biocluster.bg.